Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bäckström (Gothenburg, Sweden), G. Hamm (Cambridge, United Kingdom), M. Brülls (Gothenburg, Sweden), R. Goodwin (Cambridge, United Kingdom), M. Fridén (Gothenburg, Sweden). Revealing the regional localization and lung retention of inhaled drugs. 1023

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung – evaluation of regional lung targeting by direct sampling of epithelial lining fluid Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016 Year: 2017 The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Targeting of drugs to the lung Source: Annual Congress 2003 - COPD vs AAT deficiency - similarities and differences Year: 2003 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD Source: Eur Respir J, 54 (6) 1900521; 10.1183/13993003.00521-2019 Year: 2019 Effects of inhaled saline and oxygen on noninvasive markers of airway and lung function Source: Annual Congress 2012 - New insights in the clinical management of lung diseases Year: 2012 Assessing regional airways responses to inhaled bronchodilators in asthmatics Source: Annual Congress 2010 - Airways mechanics in different applications Year: 2010 Assessing regional lung ventilation with 19F-MRI of inhaled perfluoropropane Source: International Congress 2018 – Imaging biomarkers and quantitative imaging Year: 2018 The effects of inhaled acid aerosol on lung function of asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 497s Year: 2003 Prediction of efficacy of inhaled steroid on COPD by alveolar-capillary membrane permeability Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 LATE-BREAKING ABSTRACT: Effect of inhalation profiles and throat geometries on predicted lung deposition of budesonide and formoterol (BF) when inhaled through two different devices Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Lung deposition distribution in astmatic patients of inhaled steroids when inhaled at the same time or 15 minutes after formoterol Source: Eur Respir J 2004; 24: Suppl. 48, 502s Year: 2004 In-vitro emitted dose characteristics of combination budesonide / formoterol tubuhaler using patient inhalation profiles Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015 Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD Source: Eur Respir J 2016; 47: 651-654 Year: 2016 Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 245s Year: 2001 Influence of pulmonary function on spacer use for HFA-salbutamol inhalation in asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 126s Year: 2005